217 related articles for article (PubMed ID: 34750737)
21. T2 hyperintense myometrial tumors: can MRI features differentiate leiomyomas from leiomyosarcomas?
Rio G; Lima M; Gil R; Horta M; Cunha TM
Abdom Radiol (NY); 2019 Oct; 44(10):3388-3397. PubMed ID: 31250178
[TBL] [Abstract][Full Text] [Related]
22. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
[TBL] [Abstract][Full Text] [Related]
23. Uterine smooth muscle tumours with hyperintense area on T
Ando T; Kato H; Furui T; Morishige KI; Goshima S; Matsuo M
Br J Radiol; 2018 Apr; 91(1084):20170767. PubMed ID: 29308922
[TBL] [Abstract][Full Text] [Related]
24. Smooth muscle tumours of the uterus: MR imaging malignant predictive features-a 12-year analysis in a referral hospital in Portugal.
Freitas P; Resende-Neves T; Lameira P; Costa M; Dias P; Filipe J; Ferreira J; Félix A; Cunha TM
Arch Gynecol Obstet; 2024 Apr; 309(4):1551-1560. PubMed ID: 38055011
[TBL] [Abstract][Full Text] [Related]
25. Uterine fibroids: correlations between MRI appearance and stiffness via magnetic resonance elastography.
Jondal DE; Wang J; Chen J; Gorny KR; Felmlee J; Hesly G; Laughlin-Tommaso S; Stewart EA; Ehman R; Woodrum DA
Abdom Radiol (NY); 2018 Jun; 43(6):1456-1463. PubMed ID: 28952003
[TBL] [Abstract][Full Text] [Related]
26. Development of a Model for the Prediction of Treatment Response of Uterine Leiomyomas after Uterine Artery Embolization.
Chung YJ; Kang SY; Chun HJ; Rha SE; Cho HH; Kim JH; Kim MR
Int J Med Sci; 2018; 15(14):1771-1777. PubMed ID: 30588202
[No Abstract] [Full Text] [Related]
27. Establishment of Noninvasive Prediction Models for the Diagnosis of Uterine Leiomyoma Subtypes.
Tamehisa T; Sato S; Sakai T; Maekawa R; Tanabe M; Ito K; Sugino N
Obstet Gynecol; 2024 Mar; 143(3):358-365. PubMed ID: 38061038
[TBL] [Abstract][Full Text] [Related]
28. Diffusion-Weighted Imaging for Differentiating Uterine Leiomyosarcoma From Degenerated Leiomyoma.
Li HM; Liu J; Qiang JW; Zhang H; Zhang GF; Ma F
J Comput Assist Tomogr; 2017; 41(4):599-606. PubMed ID: 27997438
[TBL] [Abstract][Full Text] [Related]
29. What MRI features suspect malignant pure mesenchymal uterine tumors rather than uterine leiomyoma with cystic degeneration?
Kim TH; Kim JW; Kim SY; Kim SH; Cho JY
J Gynecol Oncol; 2018 May; 29(3):e26. PubMed ID: 29400019
[TBL] [Abstract][Full Text] [Related]
30. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas.
Namimoto T; Yamashita Y; Awai K; Nakaura T; Yanaga Y; Hirai T; Saito T; Katabuchi H
Eur Radiol; 2009 Nov; 19(11):2756-64. PubMed ID: 19504102
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.
Lin G; Yang LY; Huang YT; Ng KK; Ng SH; Ueng SH; Chao A; Yen TC; Chang TC; Lai CH
J Magn Reson Imaging; 2016 Feb; 43(2):333-42. PubMed ID: 26383110
[TBL] [Abstract][Full Text] [Related]
32. Solid bone tumors of the spine: Diagnostic performance of apparent diffusion coefficient measured using diffusion-weighted MRI using histology as a reference standard.
Pozzi G; Albano D; Messina C; Angileri SA; Al-Mnayyis A; Galbusera F; Luzzati A; Perrucchini G; Scotto G; Parafioriti A; Zerbi A; Sconfienza LM
J Magn Reson Imaging; 2018 Apr; 47(4):1034-1042. PubMed ID: 28755383
[TBL] [Abstract][Full Text] [Related]
33. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications.
Yamashita Y; Torashima M; Takahashi M; Tanaka N; Katabuchi H; Miyazaki K; Ito M; Okamura H
Radiology; 1993 Dec; 189(3):721-5. PubMed ID: 8234695
[TBL] [Abstract][Full Text] [Related]
34. Ultra-high b-value diffusion-weighted imaging features of the prostatic leiomyoma-case report.
Shen Y; Zhong Y; Wang H; Ma L; Wang Y; Pan J; Sun Z; Ye H
BMC Med Imaging; 2017 Dec; 17(1):63. PubMed ID: 29262792
[TBL] [Abstract][Full Text] [Related]
35. A multiparametric MRI-based machine learning to distinguish between uterine sarcoma and benign leiomyoma: comparison with
Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Oda S; Sakamoto F; Shiraishi S; Yamashita Y
Clin Radiol; 2019 Feb; 74(2):167.e1-167.e7. PubMed ID: 30471748
[TBL] [Abstract][Full Text] [Related]
36. Uterine extension determined by MRI: a useful parameter for differentiating subserosal leiomyomas from ovarian tumors.
Kawaguchi M; Kato H; Noda Y; Furui T; Morishige KI; Hyodo F; Matsuo M
Abdom Radiol (NY); 2022 Mar; 47(3):1142-1149. PubMed ID: 34994842
[TBL] [Abstract][Full Text] [Related]
37. MR Imaging Findings of Uterine Adenomatoid Tumors.
Takeuchi M; Matsuzaki K; Bando Y; Harada M
Magn Reson Med Sci; 2024 Apr; 23(2):127-135. PubMed ID: 36697028
[TBL] [Abstract][Full Text] [Related]
38. The role of multiparametric MRI in differentiating uterine leiomyosarcoma from benign degenerative leiomyoma and leiomyoma variants: a retrospective analysis.
Mahmood NS; Al Rashid AA; Ladumor SB; Mohamed MA; Kambal AS; Saloum N; Mohamed SEMK; Al Hyassat S; Singh R
Clin Radiol; 2023 Jan; 78(1):47-54. PubMed ID: 36220736
[TBL] [Abstract][Full Text] [Related]
39. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas.
Tamai K; Koyama T; Saga T; Morisawa N; Fujimoto K; Mikami Y; Togashi K
Eur Radiol; 2008 Apr; 18(4):723-30. PubMed ID: 17929022
[TBL] [Abstract][Full Text] [Related]
40. Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma.
Sato K; Yuasa N; Fujita M; Fukushima Y
Am J Obstet Gynecol; 2014 Apr; 210(4):368.e1-368.e8. PubMed ID: 24368137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
